Dual hepatitis B and C-associated hepatocellular carcinoma: clinical characteristics, outcome, and prognostic role of albumin-bilirubin grade [0.03%]
乙型和丙型肝炎相关的肝细胞癌：临床特征、预后及白蛋白-胆红素分级的作用
Chih-Chieh Ko,Shu-Yein Ho,Po-Hong Liu et al.
Chih-Chieh Ko et al.
Background: Albumin-bilirubin (ALBI) grade is used to evaluate the outcome of patients with hepatocellular carcinoma (HCC) which is often associated with chronic hepatitis B virus (HBV) or hepatitis C virus (HCV) infectio...
Postoperative lymphocyst formation after pelvic lymphadenectomy for gynecologic cancers: comparison between laparoscopy and laparotomy [0.03%]
妇科盆腔淋巴结清扫术后淋巴囊肿的形成：腹腔镜与开腹手术对比研究
Reisa Kakubari,Eiji Kobayashi,Mamoru Kakuda et al.
Reisa Kakubari et al.
Purpose: The goal of this study was to evaluate, using definitive diagnostic criteria, the incidence of lymphocyst formation following pelvic lymphadenectomy for gynecological cancer, and to compare rates between the appr...
Novel diagnostic model for bone metastases in renal cell carcinoma patients based on bone scintigraphy analyzed by computer-aided diagnosis software and bone turnover markers [0.03%]
基于核素骨扫描和计算机辅助诊断软件分析及骨代谢标志物的肾癌骨转移诊断模型研究
Takeshi Ujike,Motohide Uemura,Taigo Kato et al.
Takeshi Ujike et al.
Background: Computer-assisted diagnosis (CAD) systems for bone scans have been introduced as clinical quality assurance tools, but few studies have reported on its utility for renal cell carcinoma (RCC) patients. The aim ...
Cancer risk and genotype-phenotype correlation in Japanese patients with Cowden syndrome [0.03%]
日本Cowden综合征患者的癌症风险和基因型表型相关性研究
Satoshi Teramae,Naoki Muguruma,Koichi Okamoto et al.
Satoshi Teramae et al.
Background: Cowden syndrome (CS) is an autosomal-dominant hereditary disorder caused by a germline PTEN variant and characterized by multiple hamartomas and a high risk of cancers. However, no detailed data on CS in Asian...
Correction to: Real-world use of enzalutamide in men with nonmetastatic castration-resistant prostate cancer in Japan [0.03%]
非转移性去势抵抗性前列腺癌日本患者的恩扎卢胺使用情况（Letter to the Editor）
Akira Yokomizo,Junji Yonese,Shin Egawa et al.
Akira Yokomizo et al.
Treatments for elderly cancer patients and reforms to social security systems in Japan [0.03%]
日本老年癌症患者的治疗及社会保障制度改革
Fumio Nagashima,Junji Furuse
Fumio Nagashima
In Japan, the population aged 65 years and above accounts for 29% of the total population. Furthermore, the number of cancer patients among the elderly is increasing. Geriatric oncology is a discipline that deals with appropriate care for e...
Phase II study of carboplatin-paclitaxel alone or with bevacizumab in advanced sarcomatoid carcinoma of the lung: HOT1201/NEJ024 [0.03%]
卡铂-紫杉醇单用或联合贝伐珠单抗治疗肺肉瘤样癌患者的Ⅱ期研究(HOT1201/NEJ024)
Satoshi Oizumi,Kei Takamura,Toshiyuki Harada et al.
Satoshi Oizumi et al.
Objectives: Only a few prospective studies have been conducted to examine the efficacy and safety of systemic chemotherapy for patients with pulmonary sarcomatoid carcinomas (PSCs). There is, thus, a crucial need to devel...
Proposal for a tumor budding predictive score derived from endoscopic biopsy samples in colorectal cancer [0.03%]
基于内镜活检标本的结直肠癌肿瘤浸润评分构建方案
Masato Yamadera,Eiji Shinto,Ken Nagata et al.
Masato Yamadera et al.
Background: In colorectal cancer, tumor budding is highlighted as both a prognostic indicator and a predictor of chemosensitivity. However, tumor budding has a serious drawback because of unattainable preoperative assessm...
Nanoparticle albumin-bound paclitaxel and ramucirumab versus paclitaxel and ramucirumab as second-line chemotherapy for unresectable advanced or recurrent gastric cancer: a multicenter, propensity score-matched analysis (CROSS SELL study) [0.03%]
纳米白蛋白颗粒结合紫杉醇联合雷莫卢单抗对比紫杉醇联合雷莫卢单抗二线治疗不可切除的晚期或复发性胃癌的多中心倾向匹配分析(CROSS SELL研究)
Akio Nakasya,Yuya Hagiwara,Tatsuki Ikoma et al.
Akio Nakasya et al.
Background: Paclitaxel plus ramucirumab (PTX + RAM) is the standard second-line chemotherapy for unresectable advanced or recurrent gastric cancer (AGC). Nanoparticle albumin-bound paclitaxel (nab-PTX) is an improved, mor...
Toshiyuki Kunisada,Eiji Nakata,Tomohiro Fujiwara et al.
Toshiyuki Kunisada et al.
Soft-tissue sarcoma is a rare cancer that accounts for approximately 1% of all malignant tumors. Although they occur in various age groups, soft-tissue sarcomas account for 8% of all malignant tumors developing in adolescents and young adul...